Biosimilars: the process is the product. The example of recombinant streptokinase

BACKGROUND: Worldwide, streptokinase remains the most used thrombolytic agent for the treatment of myocardial infarction. Recombinant streptokinase, from E. coli, is increasingly used in developing countries as a biosimilar of native streptokinase; however, potency assignments relative to the WHO In...

Descripción completa

Detalles Bibliográficos
Autores principales: Thelwell, C, Longstaff, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241032/
https://www.ncbi.nlm.nih.gov/pubmed/24913658
http://dx.doi.org/10.1111/jth.12629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241032/
https://www.ncbi.nlm.nih.gov/pubmed/24913658
http://dx.doi.org/10.1111/jth.12629

Ejemplares similares